Malo P E, Wasserman M A, Torphy T J, Parris D J, Pfeiffer D F
J Pharmacol Exp Ther. 1986 Jun;237(3):782-6.
In light of current interest in substance P as a bronchoconstrictor, several pharmacologic antagonists of known mediators of anaphylaxis were tested for possible activity against this neuropeptide. Concentration-dependent contractions of the isolated guinea-pig tracheal strips to substance P (10(-8) to 10(-5) M) were elicited. These contractions were inhibited by substance P receptor antagonists, D-Arg1-D-Trp7,9-Leu11 and D-Pro2-D-Trp7,9-substance P (10(-6) to 10(-4) M). Substance P-induced contractions were not inhibited by histamine, alpha and beta adrenergic receptor antagonists or by cyclooxygenase inhibition. However, atropine enhanced contractions to substance P. Both vasoactive intestinal polypeptide (10(-7), 10(-6) and 10(-4) M) and isoproterenol (10(-7) M) were able to reverse an ongoing substance P (10(-5) M)-induced contraction. Also, at a concentration of 10(-5) M, substance P increased cyclic GMP accumulation, but had no effect on the concentration of cyclic AMP. A 15-min pretreatment with either verapamil or nifedipine (10(-8) M) had no effect on substance P-induced contractions, whereas the purported intracellular Ca++ antagonist, 8-[N,N-diethylamino]-octyl 3,4,5-trimethoxybenzoate hydrochloride (10(-4) M) produced a rightward shift of a substance P concentration-response curve. A selective calmodulin inhibitor, N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfonamide (10(-4) M) failed to affect the contraction produced by 10(-5) M substance P. When guinea-pig tracheal strips were washed and allowed to re-equilibrate in 0 Ca++ buffer, the initial maximum contractions to substance P (10(-5) M) were equal for both regular (1.8 mM) Ca++ and 0 Ca++ buffer.(ABSTRACT TRUNCATED AT 250 WORDS)
鉴于目前对P物质作为支气管收缩剂的关注,对几种已知的过敏反应介质的药理学拮抗剂进行了测试,以确定其对这种神经肽的可能活性。引发了分离的豚鼠气管条对P物质(10(-8)至10(-5)M)的浓度依赖性收缩。这些收缩被P物质受体拮抗剂D-Arg1-D-Trp7,9-Leu11和D-Pro2-D-Trp7,9-P物质(10(-6)至10(-4)M)抑制。P物质诱导的收缩不受组胺、α和β肾上腺素能受体拮抗剂或环氧化酶抑制的影响。然而,阿托品增强了对P物质的收缩。血管活性肠肽(10(-7)、10(-6)和10(-4)M)和异丙肾上腺素(10(-7)M)都能够逆转正在进行的P物质(10(-5)M)诱导的收缩。此外,在10(-5)M的浓度下,P物质增加了环鸟苷酸的积累,但对环腺苷酸的浓度没有影响。用维拉帕米或硝苯地平(10(-8)M)进行15分钟的预处理对P物质诱导的收缩没有影响,而所谓的细胞内钙拮抗剂盐酸8-[N,N-二乙氨基]-辛基3,4,5-三甲氧基苯甲酸酯(10(-4)M)使P物质浓度-反应曲线向右移动。一种选择性钙调蛋白抑制剂N-(6-氨基己基)-5-氯-1-萘磺酰胺(10(-4)M)未能影响10(-5)M P物质产生的收缩。当豚鼠气管条在0钙缓冲液中洗涤并重新平衡时,对于正常(1.8mM)钙缓冲液和0钙缓冲液,对P物质(10(-5)M)的初始最大收缩是相等的。(摘要截断于250字)